JIPLP: So when is a patent claim too broad?

The Journal of Intellectual Property Law and Practice has published an article by Andrew Sharples and Carissa Kendall-Palmer about the Court of Appeal’s decision in Regeneron Pharmaceuticals Inc v Genentech Inc.

This ruling confirms that a broad claim in a patent encompassing a large number of unexemplified embodiments can be valid and enforceable.

To read the JIPLP article in full, click here.

Subscribe to The Patent Strategist newsletter

Thank you for your interest.

Subscribe to The Patent Strategist newsletter

Get expert insights and the top patent stories delivered straight to your inbox.